Ross Ward

8PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 10, 2026
Leveraging cDC1 biology and function for enhanced immunotherapy.

|Jul 27, 2025
The source of dietary fat influences anti-tumour immunity in obese mice.

Britta Kunkemoeller, Hannah Prendeville, Claire McIntyre

|Jan 22, 2025
Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion.

Alessia Zotta, Juliana Toller-Kawahisa, Eva M Palsson-McDermott

|Nov 23, 2023
Rational design of polymer-based particulate vaccine adjuvants.

Jorge Huete-Carrasco, Roisin I Lynch, Ross W Ward

|Dec 16, 2022
Myeloid cell-derived proteases produce a proinflammatory form of IL-37 that signals via IL-36 receptor engagement.

Graeme P Sullivan, Pavel Davidovich, Natalia Muñoz-Wolf

Pageof 2